Commitment to spend, operational expenses, initial lease term Leasehold Interest, Operational Expenses, Commitment to Spend, Initial Lease Term Leasehold Interest, Operational Expenses, Commitment to Spend, Initial Lease Term Termination fee Collaboration Agreements, Termination Fee Collaboration Agreements, Termination Fee Expansion Premises Expansion Premises [Member] Amendment for expansion of premises, lease term. Payments as a percentage of net sales Revenue Interest Purchase Agreement, Payments, Percentage Of Net Sales Revenue Interest Purchase Agreement, Payments, Percentage Of Net Sales Consolidated Entities Consolidated Entities [Axis] Variable Rate [Domain] Variable Rate [Domain] Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Net loss attributable to noncontrolling interests, net of tax Net Income (Loss) Attributable to Noncontrolling Interest Accrued expenses and other liabilities Accrued Liabilities, Current Statistical Measurement Statistical Measurement [Domain] Research and development (including amounts with related parties) Research and development expense Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Long-Term Debt [Roll Forward] Long-Term Debt [Roll Forward] Long-Term Debt Award Type Award Type [Domain] Investment, Name [Domain] Investment, Name [Domain] Nonvested, beginning balance (in units) Nonvested, ending balance (in units) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Investment accretion income (amortization expense), net Investment Income, Net, Amortization of Discount and Premium Revenue Interest Purchase Agreement Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Additional revenue interests, second payment Purchase Agreement, Additional Revenue Interests, Second Payment Purchase Agreement, Additional Revenue Interests, Second Payment Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Summary of Available-for-Sale Marketable Debt Securities Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] ATM Offering Program At The Market Offering Program [Member] At-The-Market offering program. NANTibody, LLC NANTibody, LLC [Member] NANTibody, LLC Prepaid research and development costs Prepaid Research And Development Costs Prepaid Research And Development Costs 605 Nash, LLC Six Zero Five Nash, LLC [Member] Six Zero Five Nash, LLC Accounts payable Accounts Payable, Current Research and Development [Abstract] Research and Development [Abstract] Investment, Name [Axis] Investment, Name [Axis] 2015 Equity Incentive Plan Two Thousand Fifteen Equity Incentive Plan [Member] Two thousand fifteen equity incentive plan. Revenue Interest Purchase Agreement Revenue Interest Purchase Agreement [Member] Revenue Interest Purchase Agreement Total other expense, net Nonoperating Income (Expense) Commitments and contingencies (Note 8) Commitments and Contingencies Volatility Expected average volatility Measurement Input, Price Volatility [Member] Operating Leases Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Accounting Policies [Line Items] Accounting Policies [Line Items] Accounting policies. Summary of RSU Activity under Equity Plans Nonvested Restricted Stock Shares Activity [Table Text Block] Initial measurement of warrants issued in connection with RDOs accounted for as liabilities Issuance Of Warrants Issuance Of Warrants Stockholders’ Deficit Equity [Text Block] Proceeds from equity offerings, net of discounts and issuance costs Proceeds from Issuance of Common Stock Other assets Increase (Decrease) in Other Noncurrent Assets Geographical Geographical [Axis] 2015 Share Repurchase Plan Two Thousand Fifteen Share Repurchase Plan [Member] 2015 share repurchase plan. Less: Tenant improvement allowance receivable Finance Lease, Liability, Tenant Improvement Allowance Receivable Finance Lease, Liability, Tenant Improvement Allowance Receivable Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Taxes Income Tax Disclosure [Text Block] Ownership Ownership [Axis] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Restricted cash Restricted Cash and Cash Equivalents, Noncurrent Fair Value, Stock Purchase Option, Revenue Interest Purchase Agreement Fair Value, Stock Purchase Option, Revenue Interest Purchase Agreement [Member] Fair Value, Stock Purchase Option, Revenue Interest Purchase Agreement Current liabilities: Liabilities, Current [Abstract] Lease-related payables Lease Related Payables Lease-related payables. Business Acquisition [Line Items] Business Acquisition [Line Items] Warrant Liabilities Warrant Liability [Text Block] Warrant Liability Subsequent Event Type [Domain] Subsequent Event Type [Domain] Weighted- Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Forfeited/expired (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Initial Premises Initial Premises [Member] Initial Premises. Net loss per ImmunityBio common share - diluted (in dollars per share) Earnings Per Share, Diluted Unrealized gains on marketable debt securities, net Unrealized Gain (Loss) on Investments Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Accrued research and development costs Accrued Research And Development Costs Accrued research and development costs. Stock Options, Other Exercise of Stock Options [Member] Exercise of Stock Options Vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Level 3 Fair Value, Inputs, Level 3 [Member] Treasury stock, common shares (in shares) Treasury Stock, Common, Shares Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Collaboration and License Agreements and Acquisition Research, Development, and Computer Software Disclosure [Text Block] Litigation Case [Axis] Litigation Case [Axis] Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Warrant exercises (in shares) Number of warrants exercised (in shares) Class of Warrant or Right, Exercised Class of Warrant or Right, Exercised Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Summary of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Net loss attributable to ImmunityBio common stockholders Net Income (Loss) Attributable to Parent Altor Stockholders Altor Stockholders [Member] Altor Stockholders Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Total current liabilities Liabilities, Current Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] 2026 Finance Lease, Liability, to be Paid, Year Two Lease Arrangements Lessee, Operating Leases [Text Block] Gross Carrying Amount Intangible Assets, Gross (Excluding Goodwill) LIABILITIES AND STOCKHOLDERS’ DEFICIT Liabilities and Equity [Abstract] Amortization of related-party notes discounts Amortization of Debt Discount (Premium) Stockholders’ deficit: Equity, Attributable to Parent [Abstract] $505 Million Promissory Note, December 2023, Tranche 2 $505 Million Promissory Note, December 2023, Tranche 2 [Member] $505 Million Promissory Note, December 2023, Tranche 2 Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Deferred revenue Contract with Customer, Liability Exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Brink Biologics, Inc. Brink Biologics, Inc. [Member] Brink Biologics, Inc. Related-party convertible notes and accrued interest, net of discount (Note 11) Convertible Notes Payable, Noncurrent License maintenance fees payable Collaboration Agreements, License Maintenance Fees Payable Collaboration Agreements, License Maintenance Fees Payable Cost of product revenue Cost of Goods and Services Sold Effect of exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Number of Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Noncurrent Liabilities Noncurrent Liabilities [Member] Noncurrent Liabilities Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Level 1 Fair Value, Inputs, Level 1 [Member] Marketable securities Marketable Securities, Current Summary of Property, Plant and Equipment, Net Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Exercise price of warrants (in dollars per share) Exercise price of warrants exercised (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Financial Instruments Financial Instruments [Domain] Common stock reserved for future grants (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Sorrento Therapeutics, Inc. Litigation Sorrento Therapeutics, Inc. Litigation [Member] Sorrento Therapeutics, Inc. Litigation Investment Type Investment Type [Axis] Lessee Lease Description [Table] Lessee, Lease, Description [Table] 2026 Long-Term Debt, Maturity, Year Two Asset Acquisition [Domain] Asset Acquisition [Domain] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business Investments Investments [Domain] 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four Contingent Consideration by Type Contingent Consideration by Type [Axis] Related-party convertible notes Related Party, Convertible Notes [Member] Related Party, Convertible Notes Local Phone Number Local Phone Number Shared Services Agreement Shared Services Agreement [Member] Shared services agreement. Accounts receivable Increase (Decrease) in Accounts Receivable Transaction Transaction [Domain] Annual payment for support of research activities Collaboration Agreements, Annual Payment For Support Of Research Activities Annual payment for support of research activities. Selling, general and administrative Selling, General and Administrative Expenses [Member] 2024 (excluding the six months ended June 30, 2024) Long-Term Debt, Maturity, Remainder of Fiscal Year Accounts receivable, net Accounts Receivable [Member] Proceeds from Second Payment, net of issuance costs Proceeds From Issuance Of Secured Debt, Gross Proceeds From Issuance Of Secured Debt, Gross Tenant improvements incentive Incentive from Lessor Exercise of stock option Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Foreign bonds Foreign Government Debt [Member] Measurement Frequency Measurement Frequency [Axis] Outstanding third-party warrants Exercise of stock option Warrant [Member] Operating lease liabilities, less current portion (including amounts with related parties) Operating lease liabilities Operating Lease, Liability, Noncurrent Outstanding RSUs RSUs Restricted Stock Units (RSUs) [Member] Accounts payable Increase (Decrease) in Accounts Payable, Trade Class of Warrant or Right [Table] Class of Warrant or Right [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Depreciation expense related to property, plant and equipment Depreciation Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Summary of Estimated Future Contractual Obligations for Related-Party Debt Contractual Obligation, Fiscal Year Maturity [Table Text Block] Debt issuance costs Payments of Debt Issuance Costs Income Tax [Table] Income Tax [Table] Income tax. Potential contingent value rights to be earned Contingent Value Rights Obligations Contingent value rights obligations. Income Statement Location Income Statement Location [Axis] Transaction Type Transaction Type [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] 2023 through 2030 Collaborative Arrangement and Arrangement Other than Collaborative, Fee, Tranche Two [Member] Collaborative Arrangement and Arrangement Other than Collaborative, Fee, Tranche Two Net share settlement for RSUs vesting Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Summary of Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Ownership percentage acquired Percentage Of Wholly Owned Subsidiary Percentage of wholly-owned subsidiary. Commissions and offering costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Cost of Product Revenue Cost of Goods and Service [Policy Text Block] Risk-free rate Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Fair Value by Liability Class Fair Value by Liability Class [Domain] Summary of Accrued Expenses and Other Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Summary of Securities Excluded from the Computation of Potentially Dilutive Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Product and Service [Domain] Product and Service [Domain] Interest expense on related-party notes payable Interest expense recognized Interest Expense, Debt Summary of Supplemental Balance Sheet Information Related to Leases Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee Summary of Information Regarding Leases Lease, Cost [Table Text Block] Inventories Increase (Decrease) in Inventories Accrued expenses and other liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Research and development expense Research and development Research and Development Expense [Member] Investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Change in fair value of convertible note Fair Value, Option, Changes in Fair Value, Gain (Loss) Period Two Period Two [Member] Period Two Award Type Award Type [Axis] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Granted (in units) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name Plan Name [Domain] Document Quarterly Report Document Quarterly Report Litigation [Line Items] Litigation [Line Items] Litigation. Supplemental disclosure of non-cash activities: Noncash Investing and Financing Items [Abstract] Interest expense (including amounts with related parties) Interest expense (including amounts with related parties) Interest Expense Unrecognized compensation cost related to non-vested stock options Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Property and equipment purchases included in accounts payable, accrued expenses and due to related parties Capital Expenditures Incurred but Not yet Paid Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Financial Statement Details Additional Financial Information Disclosure [Text Block] Gross property, plant and equipment Property, Plant and Equipment, Gross Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 2024 (excluding the six months ended June 30, 2024) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Related-Party Debt Related-Party Agreements Related Party Transactions Disclosure [Text Block] Less: Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Summary of Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Change in fair value of derivative liabilities Change in Fair Value of Derivative Liabilities Change in Fair Value of Derivative Liabilities Period Four Period Four [Member] Period Four Use of Estimates Use of Estimates, Policy [Policy Text Block] Total lease assets Lease, Right-Of-Use Asset Lease, Right-Of-Use Asset Lease Arrangements Lessee, Finance Leases [Text Block] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] $505 Million Promissory Note, December 2023 $505 Million Promissory Note, December 2023 [Member] $505 Million Promissory Note, December 2023 Entity File Number Entity File Number Contingent consideration obligations Contingent Consideration [Member] Contingent Consideration Favorable Leasehold Rights Off-Market Favorable Lease [Member] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] VivaBioCell VivaBioCell [Member] VivaBioCell. Debt discount Less: Unamortized Discounts Debt Instrument, Unamortized Discount Risk-free rate Measurement Input, Discount Rate [Member] Operating lease liabilities (including amounts with related parties) Operating lease liabilities Operating Lease, Liability, Current Duley Road, LLC Duley Road, LLC [Member] Duley Road, LLC. Maximum milestone payment due if certain conditions are met Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High Tiered Payments [Domain] Tiered Payments [Domain] Tiered Payments [Domain] Amortization expense Amortization of Intangible Assets Entity Shell Company Entity Shell Company 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three Business Acquisition, Acquiree Business Acquisition, Acquiree [Domain] Net Carrying Amount Finite-Lived Intangible Assets, Net Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] 23 Alaska, LLC 23 Alaska, LLC [Member] 23 Alaska, LLC Nant Cell Inc Nant Cell Inc [Member] NantCell, Inc. Prepaid services Prepaid Services Prepaid services. Counterparty Name [Domain] Counterparty Name [Domain] Asset Class Asset Class [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Expected term Measurement Input, Expected Term [Member] Optional extended term of supply agreement Supply Agreement, Period Of Extended Term Supply Agreement, Period Of Extended Term Sale of stock (in dollars per share) Sale of Stock, Price Per Share Registered Direct Offering Private Placement [Member] Variable lease costs Variable Lease, Cost Operating lease costs Operating Lease, Cost More than 12 months, Estimated Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Common stock, shares issued (in shares) Common Stock, Shares, Issued Vested (in units) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Business combination, consideration transferred Business Combination, Consideration Transferred Total Lease, Liability, To Be Paid [Abstract] Lease, Liability, To Be Paid Altor BioScience Corporation Altor BioScience Corporation [Member] Altor BioScience Corporation. Schedule of Weighted Average Fair Value of Options Under Black-Scholes Option Pricing Model Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Revenue interest liability, at December 31, 2023 Revenue interest liability, at June 30, 2024 Total Long-Term Debt 2026 Lease, Liability, To Be Paid, Year Two Lease, Liability, To Be Paid, Year Two Assets measured at fair value Assets, Fair Value Disclosure Sale of stock issued in transaction Sale of Stock, Consideration Received on Transaction Selling, general and administrative (including amounts with related parties) Selling, General and Administrative Expense Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Outstanding stock options Stock options Share-Based Payment Arrangement, Option [Member] Total lease liabilities Lease, Liability Lease, Liability Weighted-average period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition $200 Million September 2023 Promissory Note $200 Million September 2023 Promissory Note [Member] $200 Million September 2023 Promissory Note Asset Acquisition [Table] Asset Acquisition [Table] Number of square foot of facility leased Number Of Square Feet Of Facility Leased Number of square feet of facility leased. Maximum Maximum [Member] Comprehensive loss attributable to ImmunityBio common stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Summary of Outstanding Balances of Related-Party Agreements Schedule of Related Party Transactions [Table Text Block] Income Tax [Line Items] Income Tax [Line Items] Income tax. Aggregate intrinsic value, vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Short-term lease costs Short-Term Lease, Cost Summary of Interest and Investment Income (Loss), Net Interest and Other Income [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Marketable securities, noncurrent Marketable Securities, Noncurrent Inventory Inventory, Policy [Policy Text Block] Embedded Derivative Financial Instruments Embedded Derivative Financial Instruments [Member] Non-refundable upfront cash payments Collaboration Agreements, Nonrefundable Upfront Payment Nonrefundable upfront payment. 2025 Lease, Liability, To Be Paid, Year One Lease, Liability, To Be Paid, Year One 2027 Finance Lease, Liability, to be Paid, Year Three Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Subsequent Event [Table] Subsequent Event [Table] Fair Value Option Election Convertible Notes, Fair Value Option Election [Policy Text Block] Convertible Notes, Fair Value Option Election Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Thereafter Lessee, Operating Lease, Liability, to be Paid, Due after Year Four Lessee operating lease liability payments due after year four. Percentage of ownership interest Subsidiary, Ownership Percentage, Parent Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Non-cash interest items, net (including amounts with related parties) Other Noncash Income (Expense) Deferred Revenue Arrangement [Line Items] Deferred Revenue Arrangement [Line Items] Purchases of marketable debt securities, available-for-sale Payments to Acquire Debt Securities, Available-for-Sale 2025 Finance Lease, Liability, to be Paid, Year One Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] September 2019 Lease September Twenty Nineteen Lease [Member] September twenty nineteen lease. Duley Road, LLC Duley Road [Member] Duley Road. Business Acquisition Business Acquisition [Axis] July 2023 Warrants July 2023 Warrants [Member] July 2023 Warrants Subsequent Event Subsequent Event [Member] Variable Rate [Axis] Variable Rate [Axis] Income Statement [Abstract] Income Statement [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Issuance of common stock, net (in shares) Stock Issued During Period, Shares, New Issues Title of 12(b) Security Title of 12(b) Security Expected market yield Measurement Input, Expected Market Yield [Member] Measurement Input, Expected Market Yield Amount awarded from other party in litigation settlement Litigation Settlement, Amount Awarded from Other Party NCSC NCSC [Member] NCSC. Revenue interest purchase agreement, payment received percentage Revenue Interest Purchase Agreement, Payment Received Percentage Revenue Interest Purchase Agreement, Payment Received Percentage Asset Acquisition [Line Items] Asset Acquisition [Line Items] Related Party Related Party, Type [Domain] Percentage of sales agent commission Percentage Of Sales Agent Commission Percentage Of Sales Agent Commission Net Carrying Amount Indefinite-Lived Intangible Assets (Excluding Goodwill) Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Accrued expenses and other current liabilities Accrued Expenses and Other Current Liabilities [Member] Accrued Expenses and Other Current Liabilities Exercise of warrants Proceeds from exercise of warrants Stock Issued During Period, Value, Warrants Exercised Stock Issued During Period, Value, Warrants Exercised Nonvested, beginning balance (in dollars per share) Nonvested, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Other Other Assets, Current Initial term of supply agreement Supply Agreement, Term Of Contract Supply Agreement, Term Of Contract Accrued revenue interest payment Accrued Revenue Interest Payment Accrued Revenue Interest Payment Class Of Stock [Line Items] Class of Stock [Line Items] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Accrued preclinical and clinical trial costs Accrued Preclinical And Clinical Trial Costs Accrued preclinical and clinical trial costs. Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Inventories Inventories Inventory, Net Total lease expense Lease, Cost Periodic license payments Collaboration Agreements, Periodic License Payments Collaboration Agreements, Periodic License Payments Derivative Liabilities Derivative Liabilities [Member] Derivative Liabilities Statistical Measurement Statistical Measurement [Axis] Financial Instrument Financial Instrument [Axis] Balance Sheet Location Balance Sheet Location [Domain] Gross Carrying Amount Indefinite Lived Intangible Assets, Gross, Excluding Goodwill Indefinite Lived Intangible Assets, Gross, Excluding Goodwill Entity Interactive Data Current Entity Interactive Data Current Research And Development Arrangements With Federal Government [Table] Research And Development Arrangements With Federal Government [Table] Research And Development Arrangements With Federal Government [Table] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Schedule Of Available For Sale Securities [Table] Debt Securities, Available-for-Sale [Table] Reconciliation of cash, cash equivalents, and restricted cash, end of period: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Product revenue, net Product [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Financial Statement Details [Table] Financial Statement Details [Table] Financial Statement Details [Table] Total ImmunityBio Stockholders’ Deficit Parent [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Outstanding related-party warrants Related Party Warrants [Member] Related Party Warrants Reimbursements Reimbursements [Member] Reimbursements. Litigation [Table] Litigation [Table] Litigation. Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Vesting of restricted stock units (RSUs) (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Prepaid equipment maintenance Prepaid Equipment Maintenance Prepaid equipment maintenance. Revenues Revenue from Contract with Customer [Policy Text Block] Face amount Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Security deposits Security Deposit Accrued expenses and other liabilities Accounts Payable and Other Accrued Liabilities, Current Entity Address, State or Province Entity Address, State or Province Counterparty Name [Axis] Counterparty Name [Axis] Total future minimum lease payments Finance Lease, Liability, to be Paid Operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Promissory Notes Promissory Notes Payable [Member] Promissory Notes Payable Accrued construction costs Accrued Construction Costs, Current Accrued Construction Costs, Current Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Schedule Of Related Party Transactions By Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Estimated benefit at grant date fair value Share Based Compensation Arrangement By Share Based Payment Award Estimated Benefit At Grant Date Fair Value Share based compensation arrangement by share based payment award estimated benefit at grant date fair value. 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Unpaid offering costs included in accounts payable and accrued expenses Unpaid Offering Costs Included In Accounts Payable And Accrued Expenses Unpaid offering costs included in accounts payable and accrued expenses. Cash paid for operating leases (excluding variable lease costs) Operating Lease, Payments Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Maturities of marketable debt securities, available-for-sale Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Required purchase price, as a percent Revenue Interest Purchase Agreement, Percentage of Cumulative Purchaser Payments, Repurchase Price Revenue Interest Purchase Agreement, Percentage of Cumulative Purchaser Payments, Repurchase Price Option Period [Domain] Option Period [Domain] Option Period [Domain] Dividends Dividends Percent of common stock outstanding after option exercise, maximum Sale of Stock, Percentage of Ownership after Transaction Other Other Operating Activities, Cash Flow Statement Asset Class Asset Class [Domain] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock Sale of Stock [Axis] Interest related to litigation settlement (as a percent) Litigation Settlement Interest, Percent Litigation Settlement Interest, Percent Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Warrants Warrants [Policy Text Block] Warrants Summary of Inventories Schedule of Inventory, Current [Table Text Block] Non-cash interest expense related to the revenue interest liability Interest Expense, Nonoperating, Secured Debt, Net Interest Expense, Nonoperating, Secured Debt, Net Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of securities in an unrealized loss position Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Debt Instrument [Axis] Debt Instrument [Axis] Present value of lease liabilities Operating Lease, Liability 2024 (excluding the six months ended June 30, 2024) Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Measurement Input Type [Domain] Measurement Input Type [Domain] Unrealized losses from equity securities Debt and Equity Securities, Unrealized Gain (Loss) Vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Collaborative Arrangement and Arrangement Other than Collaborative, Fee Schedule [Axis] Collaborative Arrangement and Arrangement Other than Collaborative, Fee Schedule [Axis] Collaborative Arrangement and Arrangement Other than Collaborative, Fee Schedule Total liabilities Liabilities Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Asset Acquisition [Axis] Asset Acquisition [Axis] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Prepaid software license fees Prepaid Software License Fees Prepaid software license fees. Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Contingent Value Rights Payable, Sales Milestone Contingent Value Rights Obligation, Sales Milestone [Member] Contingent value rights obligation before December 31, 2026. Measurement Frequency Measurement Frequency [Domain] February 2023 Shelf Registration Statement February 2023 Shelf Registration Statement [Member] February 2023 Shelf Registration Statement Sponsored Research Agreement Sponsored Research Agreement [Member] Sponsored research agreement. Current Assets Current Assets [Member] Current assets. Accrued bonus Accrued Bonuses, Current Plan Name Plan Name [Axis] Embedded contingent derivative liability related to Second Payment Embedded contingent derivative liability related to Second Payment Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Related Party Transaction Related Party Transaction [Domain] Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Annual lease payment Lease, Operating Lease, Annual Lease Payment Lease, Operating Lease, Annual Lease Payment Subsequent Event [Line Items] Subsequent Event [Line Items] Affiliated Entity Affiliated Entity [Member] Common stock, $0.0001 par value; 1,350,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 691,793,169 and 670,867,344 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively; excluding treasury stock, 163,800 shares outstanding as of June 30, 2024 and December 31, 2023 Common Stock, Value, Issued Sale of stock, additional purchase option Sale Of Stock, Additional Purchase Option Sale Of Stock, Additional Purchase Option Less than 12 months, Estimated Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Stock Purchase And Option Agreement Stock Purchase And Option Agreement [Member] Stock Purchase And Option Agreement Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Accrued professional and service fees Accrued Professional Fees, Current Non-cash lease expense related to operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Total current assets Assets, Current Advances to support operations Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Principal payments of finance leases Financing cash flow from finance leases Finance Lease, Principal Payments Government funding for leasehold build-out Leasehold Interest, Government Funding Available Leasehold Interest, Government Funding Available Equity securities Equity Securities [Member] Revenue from Contract with Customer [Abstract] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Cash Flow Operating Activities Lessee [Abstract] Cash Flow, Operating Activities, Lessee [Abstract] December 2022 Warrants December 2022 Warrants [Member] December 2022 Warrants Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Litigation Case [Domain] Litigation Case [Domain] Other expense, net (including amounts with related parties) Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Proceeds from the RIPA, net of issuance costs Proceeds from Issuance of Secured Debt Statement [Table] Statement [Table] Revenue interest liability (Note 10) Revenue interest liability Secured Long-Term Debt, Noncurrent Current Fiscal Year End Date Current Fiscal Year End Date Basic and Diluted Net Loss per Share of Common Stock Earnings Per Share, Policy [Policy Text Block] State Of New York State Of New York [Member] State Of New York Unrecognized tax benefits Unrecognized Tax Benefits 420 Nash, LLC Four Two Zero Nash, LLC [Member] Four Two Zero Nash, LLC Interest expense related to revenue interest liability Interest Expense, Nonoperating, Secured Debt Interest Expense, Nonoperating, Secured Debt Expected dividend yield Measurement Input, Expected Dividend Rate [Member] Fair value, beginning of period Fair value, end of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Debt Modification and Extinguishment, Revenue Interest Liability Debt, Policy [Policy Text Block] Warrants outstanding, beginning of period (in shares) Warrants outstanding, end of period (in shares) Number of warrants outstanding (in shares) Class of Warrant or Right, Outstanding Various Various [Member] Various. Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value February 2023 Warrants February 2023 Warrants [Member] February 2023 Warrants 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Five Prepaid insurance Prepaid Insurance 2028 Finance Lease, Liability, to be Paid, Year Four Accounts Receivable, Net Accounts Receivable [Policy Text Block] Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Summary of Future Amortization Expense Associated with Definite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Interest Payments Related Party Notes - Interest [Member] Related Party Notes - Interest Other interest expense Interest Expense, Other Immuno-Oncology Clinic, Inc. Immuno-Oncology Clinic [Member] Immuno-Oncology Clinic. Other Other Accrued Liabilities, Current Exercise of warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised Italy ITALY Change in fair value of warrant liabilities Change in fair value of warrant liabilities Fair Value Adjustment of Warrants Option Period [Axis] Option Period [Axis] Option Period Accrued compensation Accrued Salaries, Current Revenue Interest Purchase Agreement [Abstract] Revenue Interest Purchase Agreement Related parties Increase Decrease In Due To Related Parties Current And Non Current Increase decrease in due to related parties current and non current. Description of Business Nature of Operations [Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Related-party nonconvertible note, net of discount (Note 11) Other Notes Payable, Noncurrent Furniture & fixtures Furniture and Fixtures [Member] Base rent - monthly Monthly Base Rent Monthly base rent. Lease Contractual Term Lease Contractual Term [Domain] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Proceeds from exercises of warrants Proceeds from Warrant Exercises Change in fair value of related-party convertible note Gain (Loss) on Change In Fair Value, Convertible Note Gain (Loss) on Change In Fair Value, Convertible Note Total ImmunityBio stockholders’ deficit Equity, Attributable to Parent Impairment Finite-Lived Intangible Assets, Accumulated Impairment Finite-Lived Intangible Assets, Accumulated Impairment Tiered Payments [Axis] Tiered Payments [Axis] Tiered Payments Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Finance Leases Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Schedule of Unobservable Assumptions, Estimated Fair Value of Convertible Note Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Revenue recognized Contract with Customer, Liability, Revenue Recognized Convertible Notes Convertible Notes Payable [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Available for future stock issuance Sale of Stock, Amount Available For Future Stock Issuance Sale of Stock, Amount Available For Future Stock Issuance Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule Of Stock By Class [Table] Schedule of Stock by Class [Table] Total future minimum lease payments Lease, Liability, To Be Paid Lease, Liability, To Be Paid Expected term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Events [Abstract] Loss before income taxes and noncontrolling interests Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Measurement input Warrants and Rights Outstanding, Measurement Input 605 Doug St, LLC Six Zero Five Doug St, LLC [Member] Six Zero Five Doug St, LLC Mutual funds Mutual Fund [Member] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Increase to maximum offering Increase to Maximum Aggregate Stock Offering Amount Increase to Maximum Aggregate Stock Offering Amount Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Level 2 Fair Value, Inputs, Level 2 [Member] Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Share based compensation arrangement by share-based payment award, options, aggregate intrinsic value. Nant Capital Three Nant Capital Three [Member] Nant Capital Three Entity Emerging Growth Company Entity Emerging Growth Company Amyris Joint Venture Amyris Joint Venture [Member] Amyris Joint Venture Immuno-Oncology Clinic, Inc. Immuno-Oncology Clinic, Inc [Member] Immuno Oncology Clinic Inc. Intangible assets, net Net Carrying Amount Intangible Assets, Net (Excluding Goodwill) Amyris, Inc. Amyris, Inc. [Member] Amyris, Inc. Commitment to hire, number of employees, first five years Leasehold Interest, Commitment to Hire, Number of Employees, First Five Years Leasehold Interest, Commitment to Hire, Number of Employees, First Five Years Increase (Decrease) in Statements of Stockholders’ Deficit [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Weighted- Average Life (in years) Finite-Lived Intangible Asset, Useful Life Commitment to spend, operational expenses, renewal lease term Leasehold Interest, Operational Expenses, Commitment to Spend, Renewal Lease Term Leasehold Interest, Operational Expenses, Commitment to Spend, Renewal Lease Term Antidilutive Securities Antidilutive Securities [Axis] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Lease expense Operating Lease, Expense Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] Derivative Liabilities Derivatives, Embedded Derivatives [Policy Text Block] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Financial Statement Details [Abstract] Financial Statement Details [Abstract] Financial statement details. Product and Service [Axis] Product and Service [Axis] Income Statement Location Income Statement Location [Domain] Revenue, gross-to-net accruals Revenue from Contract with Customer, Gross-to-Net Accruals Revenue from Contract with Customer, Gross-to-Net Accruals Annual minimum licensing payment Collaboration Agreements, Annual Minimum Licensing Payment Collaboration Agreements, Annual Minimum Licensing Payment Percentage of ownership interest Equity Method Investment, Ownership Percentage Schedule of Changes in Carrying Amount of Warrant Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Geographical Geographical [Domain] NantWorks NantWorks, LLC [Member] NantWorks, LLC Weighted-average interest rate Debt, Weighted Average Interest Rate Total stockholders’ deficit Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Initial term of lease arrangement Lessee, Operating Lease, Term of Contract Software Software and Software Development Costs [Member] Minimum Minimum Minimum [Member] Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Summary of Stock Option Activity and Related Information under Equity Plans Share-Based Payment Arrangement, Option, Activity [Table Text Block] Total area of real estate property Area of Real Estate Property Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Warrants Warrants [Member] Warrants. Licensing Agreement [Table] Licensing Agreement [Table] Licensing agreement. Total other comprehensive loss Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Schedule of Warrant Exercise Activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Exercise price per share Measurement Input, Exercise Price [Member] Liabilities measured at fair value Liabilities, Fair Value Disclosure Insurance claims receivable Insurance Settlements Receivable, Current Operating lease liabilities Increase (Decrease) in Operating Lease Liability Non-related Party Nonrelated Party [Member] Net share settlement for RSUs vesting Payment, Tax Withholding, Share-Based Payment Arrangement Other revenues Product and Service, Other [Member] Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest U.S. Treasury securities US Treasury Securities [Member] Income taxes Income Taxes Paid, Net Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Lessee Lease Description [Line Items] Lessee, Lease, Description [Line Items] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Measurement input Embedded Derivative Liability, Measurement Input Net unrealized gains (losses) on available-for-sale securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax Accumulated Deficit Retained Earnings [Member] Convertible note receivable Convertible Note Receivable Non Current Convertible note receivable, non-current. Summary of Stock-Based Compensation Expense Included on Operations Statement Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Accretion of discounts on marketable debt securities Accretion (Amortization) of Discounts and Premiums, Investments Total liabilities and stockholders’ deficit Liabilities and Equity Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other income (expense), net Nonoperating Income (Expense) [Abstract] Other assets (including amounts with related parties) Other Assets, Noncurrent Ownership Ownership [Domain] Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Deferred Revenue Arrangement, by Type [Table] Deferred Revenue Arrangement, by Type [Table] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Net loss per ImmunityBio common share – basic (in dollars per share) Earnings Per Share, Basic Operating lease right-of-use assets, net (including amounts with related parties) Operating lease assets Operating Lease, Right-of-Use Asset Unrecognized compensation cost related to unvested stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Milestone fees Collaboration Agreements, Milestone Fees Collaboration Agreements, Milestone Fees Stock options Equity Option [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Sale of Stock Sale of Stock [Domain] NantCancerStemCell NantCancerStemCell [Member] NCSC. License maintenance fees Collaboration Agreements, License Maintenance Fees Collaboration Agreements, License Maintenance Fees Financial Statement Details [Line Items] Financial Statement Details [Line Items] Financial Statement Details [Line Items] NantBio NantBio Inc [Member] Nant Bio. Aggregate intrinsic value of stock option exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value 2024 (excluding the six months ended June 30, 2024) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Number of warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Summary of Accumulated Unrealized Losses on Marketable Debt Securities Classified as Available-for-Sale in a Continuous Loss Position Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Common Stock Value Available For Future Stock Issuance Common Stock Value Available For Future Stock Issuance Common stock value available for future stock issuance. Entity Address, City or Town Entity Address, City or Town Related Party Related Party [Member] Stock Option Purchase Liability Stock Option Purchase Liability [Member] Stock Option Purchase Liability Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Principles of Consolidation Consolidation, Policy [Policy Text Block] Document Transition Report Document Transition Report 2027 Lease, Liability, To Be Paid, Year Three Lease, Liability, To Be Paid, Year Three Schedule Of Business Acquisitions By Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Proceeds from sales of marketable debt securities Proceeds from Sale and Maturity of Marketable Securities Common stock, shares authorized (in shares) Common Stock, Shares Authorized Dunkirk Facility Dunkirk Facility [Member] Dunkirk Facility Fair Value Debt Securities, Available-for-Sale South Korea KOREA, REPUBLIC OF Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Summary of Related-Party Debt Schedule of Related-Party Promissory Notes Table [Table Text Block] Schedule of related party notes payable. Principal Amount Long-Term Debt, Gross Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Liability Class Liability Class [Axis] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Thereafter Lease, Liability, To Be Paid, After Year Four Lease, Liability, To Be Paid, After Year Four Maximum offering Sale Of Stock, Maximum Aggregate Offering Value Sale Of Stock, Maximum Aggregate Offering Value ERP system implementation cost Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization Noncurrent Assets Noncurrent Assets [Member] Noncurrent assets. 2028 Lease, Liability, To Be Paid, Year Four Lease, Liability, To Be Paid, Year Four Financial Instruments Investment [Text Block] Initial Payment Initial Payment [Member] Initial Payment Less: Comprehensive loss attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Interest income Interest and Other Income Interest and investment income (loss), net Interest and investment income (loss), net Gain (Loss) on Investments Period Three Period Three [Member] Period Three Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Forfeited/canceled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Subsequent Event Type [Axis] Subsequent Event Type [Axis] Proceeds from exercises of stock options Proceeds from stock options exercised Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Revenue interest payment Revenue Interest Payment Revenue Interest Payment Less: Tenant improvement allowance receivable Lease, Liability, Tenant Improvement Allowance Receivable Lease, Liability, Tenant Improvement Allowance Receivable Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Present value of lease liabilities Finance Lease, Liability Prepaid expenses and other current assets (including amounts with related parties) Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Principal Payments Related Party Notes - Principal [Member] Related Party Notes - Principal 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Forfeited/canceled (in units) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Prepayment and accrued interest upon specified transaction Debt Instrument, Prepayment And Accrued Interest Debt Instrument, Prepayment And Accrued Interest Collaborative Arrangement and Arrangement Other than Collaborative, Fee Schedule [Domain] Collaborative Arrangement and Arrangement Other than Collaborative, Fee Schedule [Domain] Collaborative Arrangement and Arrangement Other than Collaborative, Fee Schedule [Domain] Summary of Revenue Interest Liability Activity Summarizes the Revenue Interest Liability Activity [Table Text Block] Summarizes the Revenue Interest Liability Activity Percentage of annual increases of base rent Annual Percentage Increase To Base Rent Annual percentage increase to base rent. Interest expense (including amounts with related parties) Interest Expense, Nonoperating, Excluding Secured Debt Interest Expense, Nonoperating, Excluding Secured Debt Summary of Intangible Assets, Net Schedule of Intangible Assets and Goodwill [Table Text Block] 2025 Long-Term Debt, Maturity, Year One Thereafter Finance Lease, Liability, To Be Paid, After Year Four Finance Lease, Liability, To Be Paid, After Year Four Related Party Related Party, Type [Axis] Outstanding, beginning balance Outstanding, ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Current Liabilities Current Liabilities [Member] Current Liabilities Entity Registrant Name Entity Registrant Name 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Unrealized losses on equity securities Unrealized losses from equity securities Equity Securities, FV-NI, Unrealized Gain (Loss) Warrant liabilities Warrants and Rights Outstanding Warrants Outstanding [Roll Forward] Warrants Outstanding [Roll Forward] Warrants Outstanding Lease Contractual Term Lease Contractual Term [Axis] Noncontrolling interests Equity, Attributable to Noncontrolling Interest Initial and Expansion Premises Initial And Expansion Premises [Member] Initial And Expansion Premises Period One Period One [Member] Period One Proceeds from issuance of related-party promissory notes, net of issuance costs paid Proceeds from Related Party Debt Document Period End Date Document Period End Date Financing obligation – current portion Financing Obligation, Current Financing Obligation, Current Accounting Policies [Table] Accounting Policies [Table] Accounting policies. Less: Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Less: Interest Lease, Liability, Undiscounted Excess Interest Lease, Liability, Undiscounted Excess Interest Weighted average discount rate, finance leases Finance Lease, Weighted Average Discount Rate, Percent $30 Million March 2023 Promissory Note $30 Million March 2023 Promissory Note [Member] $30 Million March 2023 Promissory Note Entity Central Index Key Entity Central Index Key Amortization of related-party notes discounts Amortization of Debt Issuance Costs and Discounts Prepaid expenses Prepaid Expense $505 Million Promissory Note, December 2023, Tranche 1 $505 Million Promissory Note, December 2023, Tranche 1 [Member] $505 Million Promissory Note, December 2023, Tranche 1 Base monthly rent, parking Monthly Base Rent, Parking Monthly Base Rent, Parking Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Change in fair value of derivative liabilities Derivative, Gain (Loss) on Derivative, Net Related Party Notes Related Party Notes [Member] Related Party Notes Purchase price allocation Sale Of Stock And Revenue Interest Purchase Agreement, Consideration Received On Transaction Sale Of Stock And Revenue Interest Purchase Agreement, Consideration Received On Transaction Stock-based compensation expense Share-Based Payment Arrangement, Expense 2022 Collaborative Arrangement and Arrangement Other than Collaborative, Fee One [Member] Collaborative Arrangement and Arrangement Other than Collaborative, Fee One Gross Carrying Amount Finite-Lived Intangible Assets, Gross Income tax expense Income Tax Expense (Benefit) Finance lease costs (including right-of-use asset amortization and interest expense) Finance Lease Costs, Right-Of-Use Asset Amortization And Interest Expense Finance Lease Costs, Right-Of-Use Asset Amortization And Interest Expense Finished goods Inventory, Finished Goods, Net of Reserves Finance lease assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization License Agreement Terms License Agreement Terms [Member] Operating lease payments related to options to extend lease terms Operating Lease Payments Related To Options To Extend Lease Terms Operating lease payments related to options to extend lease terms. Summary of Disaggregated Revenue Disaggregation of Revenue [Table Text Block] More than 12 months, Gross Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Issuance of common stock, net Stock Issued During Period, Value, New Issues Equity [Abstract] Equity [Abstract] Schedule Of Available For Sale Securities [Line Items] Debt Securities, Available-for-Sale [Line Items] Reclassification of net realized (gains) losses on available-for-sale securities included in net loss Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Secured Overnight Financing Rate (SOFR) Secured Overnight Financing Rate (SOFR) [Member] Secured Overnight Financing Rate (SOFR) Weighted average remaining lease term, operating leases Operating Lease, Weighted Average Remaining Lease Term Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Due from related parties Other Receivables, Net, Current Entity Entity [Domain] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Options to extend number of terms Options To Extend Number Of Terms Options to extend number of terms. Commitment to hire, number of employees, first two and a half years Leasehold Interest, Commitment to Hire, Number of Employees, First Two and a Half Years Leasehold Interest, Commitment to Hire, Number of Employees, First Two and a Half Years Legal Entity Legal Entity [Axis] Total definite-lived intangible assets Finite-Lived Intangible Assets, Net [Abstract] Less than 12 months, Gross Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Net share settlement for RSUs vesting (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Weighted average discount rate, operating leases Operating Lease, Weighted Average Discount Rate, Percent Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Comprehensive loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Fair Value of Warrants, Carrying Amount [Roll Forward] Fair Value of Warrants, Carrying Amount [Roll Forward] Fair Value of Warrants, Carrying Amount Repurchase of common stock, shares (in shares) Stock Repurchased and Retired During Period, Shares Due to related parties Due To Related Parties [Member] Due to related parties. Revenue interest purchase agreement, tiered revenue interest rate percentage Revenue Interest Purchase Agreement, Tiered Revenue Interest Rate Percentage Revenue Interest Purchase Agreement, Tiered Revenue Interest Rate Percentage Interest rate spread Debt Instrument, Basis Spread on Variable Rate Expansion of licensed premises (in square feet) Increase to Number of Square Foot of Facility Leased Increase to Number of Square Foot of Facility Leased Contingent Consideration Type Contingent Consideration Type [Domain] Insurance premium financing asset Insurance Premium Financing Asset Insurance premium financing asset. Weighted average remaining lease term, finance leases Finance Lease, Weighted Average Remaining Lease Term Leasehold improvements Leasehold Improvements [Member] Weighted-average number of common shares used in computing net loss per share – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Fair value of warrants Warrants Not Settleable in Cash, Fair Value Disclosure Second Payment Second Payment [Member] Second Payment Increase in number of shares of common stock authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Operating costs and expenses Operating Expenses [Abstract] Number of leases Number of Lease Agreements Number of Lease Agreements Less: Interest Finance Lease, Liability, Undiscounted Excess Amount Revenues Revenue from Contract with Customer [Text Block] Impairment Indefinite-Lived Intangible Assets, Accumulated Impairment Indefinite-Lived Intangible Assets, Accumulated Impairment Research and Development Arrangements with Federal Government [Line Items] Research And Development Arrangements With Federal Government [Line Items] Research and development arrangements with the federal government. Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-in Capital Additional Paid-in Capital [Member] Balance Sheet Location Balance Sheet Location [Axis] Cash, cash equivalents, and restricted cash, beginning of period Cash, cash equivalents, and restricted cash, end of period Cash, cash equivalents, and restricted cash, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Total assets Assets Loss on equity method investment Loss on equity method investment Income (Loss) from Equity Method Investments Less: Tenant improvement allowance receivable Lessee, Operating Lease, Liability, Tenant Improvement Allowance Receivable Lessee, Operating Lease, Liability, Tenant Improvement Allowance Receivable Cover [Abstract] Cover [Abstract] Equipment Equipment [Member] Vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Repurchase price, term following closing date Revenue Interest Purchase Agreement, Percentage of Cumulative Purchaser Payments, Repurchase Price, Term Following Closing Date Revenue Interest Purchase Agreement, Percentage of Cumulative Purchaser Payments, Repurchase Price, Term Following Closing Date Subsequent Events Subsequent Events [Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Measurement input Debt Instrument, Measurement Input United States UNITED STATES Fair Value, Measurements, Recurring Fair Value, Recurring [Member] 3M IPC and Access to Advanced Health Institute License Agreement 3M IPC and Access to Advanced Health Institute License Agreement [Member] 3M IPC and Access to Advanced Health Institute License Agreement Weighted- Average Remaining Contractual Life (in years) Available For Sale Securities Debt Securities Period Available for sale securities debt securities period. Fair Value Measurements Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Operating cash flow from finance leases Finance Lease, Interest Payment on Liability Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Number of lease renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Other liabilities Other Liabilities, Noncurrent Derivative liabilities (Note 10) and (Note 11) Embedded derivative liability Embedded Derivative, Fair Value of Embedded Derivative Liability Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited/expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Transaction costs allocated to warrant liabilities Transaction Costs, Warrant Liability Transaction Costs, Warrant Liability Minimum net sales milestone for contingent value rights payable Minimum Net Sales Milestone Contingent Value Rights Obligation Minimum net sales milestone contingent value rights obligation. Dr. Soon-Shiong and Related Party Dr Soon Shiong And Related Party [Member] Dr. Soon-Shiong and related party. Construction in progress Construction in Progress [Member] Total operating costs and expenses Operating Expenses Milestone payment, aggregate maximum Collaboration Agreements, Milestone Payment, Aggregate Maximum Collaboration Agreements, Milestone Payment, Aggregate Maximum Revenue interest, investment amount Purchase Agreement, Revenue Interest Purchase Agreement, Revenue Interest 2024 (excluding the six months ended June 30, 2024) Lease, Liability, To Be Paid, Remainder of Fiscal Year Lease, Liability, To Be Paid, Remainder of Fiscal Year Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Net change in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Optional extended lease term Extended lease term Lessee, Operating Lease, Renewal Term Investments in marketable equity securities with readily determinable fair values Marketable Securities Equity Component [Domain] Equity Component [Domain] Finance lease liabilities Finance Lease, Liability, Current Work-in-progress Inventory, Work in Process, Net of Reserves Weighted-average number of common shares used in computing net loss per share – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Loss from operations Operating Income (Loss) Net realized gains (losses) on investments Realized Investment Gains (Losses) Prepaid rent Prepaid Rent Private Placement and At the Market Offerings Private Placement and At the Market Offerings [Member] Private Placement and At the Market Offerings [Member] Cash and cash equivalents Cash and Cash Equivalents [Member] Consolidated Entities Consolidated Entities [Domain] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] July 2019 Lease July Twenty Nineteen Lease [Member] July twenty nineteen lease. Related Party Transaction Related Party Transaction [Axis] Statement [Line Items] Statement [Line Items] Licensing Agreement [Line Items] Licensing Agreement [Line Items] Licensing agreement. Other comprehensive loss, net of income taxes: Other Comprehensive Income (Loss), Net of Tax [Abstract] Weighted- Average Remaining Contractual Life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Access to Advanced Health Institute (formerly IDRI) Access to Advanced Health Institute (AAHI) [Member] Access to Advanced Health Institute Noncontrolling Interests Noncontrolling Interest [Member]